Equities

Acadia Healthcare Company Inc

Acadia Healthcare Company Inc

Actions
Health CareHealth Care Providers
  • Price (USD)40.82
  • Today's Change-1.26 / -2.99%
  • Shares traded982.93k
  • 1 Year change-44.61%
  • Beta1.3036
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy5
Outperform4
Hold4
Sell0
Strong Sell0

Share price forecast in USD

The 12 analysts offering 12 month price targets for Acadia Healthcare Company Inc have a median target of 66.50, with a high estimate of 94.00 and a low estimate of 45.00. The median estimate represents a 62.91% increase from the last price of 40.82.
High130.3%94.00
Med62.9%66.50
Low10.2%45.00

Earnings history & estimates in USD

On Oct 30, 2024, Acadia Healthcare Company Inc reported 3rd quarter 2024 earnings of 0.91 per share. This result was in line with the consensus of the 12 analysts following the company and was the same as last year's 3rd quarter results.
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate+0.14%
Acadia Healthcare Company Inc reported annual 2023 earnings of 3.44 per share on Feb 27, 2024.
Average growth rate+15.06%
More ▼

Revenue history & estimates in USD

Acadia Healthcare Company, Inc. had 3rd quarter 2024 revenues of 815.63m. This missed the 819.43m consensus estimate of the 12 analysts following the company. This was 15.81% above the prior year's 3rd quarter results.
Average growth rate+2.13%
Acadia Healthcare Company, Inc. had revenues for the full year 2023 of 2.93bn. This was 12.20% above the prior year's results.
Average growth rate+0.75%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.